Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kittai

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|March 15, 2014
Neisseria meningitidis as a cause of facial cellulitisBrent Ozaki, Adam Kittai, Suzanne Chang
Chemotherapy Research and Practice|October 24, 2012
Antiepidermal growth factor receptor monoclonal antibodies: applications in colorectal cancerEfat Azizi, Adam Kittai, Peter Kozuch
BMJ Case Reports|December 25, 2014
Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remissionAdam Kittai, Eun-Mi Yu, Imad Tabbara
Anticancer Research|September 27, 2015
Chronic Lymphocytic Leukemia: Current ConceptsEun-Mi Yu, Adam Kittai, Imad A Tabbara
Cancer Biology & Therapy|July 22, 2014
Ipilimumab: a potential immunologic agent in the treatment of metastatic castration-resistant prostate cancerAdam Kittai, Mariam Meshikhes, Jeanny B Aragon-Ching
Leukemia & Lymphoma|May 22, 2019
Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cellsScott Best, Tingting Liu, Nur Bruss, et al.
British Journal of Clinical Pharmacology|July 1, 2021
Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemiaVi Lam, Scott Best, Adam Kittai, et al.
Blood Advances|January 9, 2019
Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cellsScott Best, Taylor Hashiguchi, Adam Kittai, et al.
Cancer Management and Research|December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution ExperienceAndrew Schaefer, Ying Huang, Adam Kittai, et al.
Leukemia|March 24, 2020
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cellsScott Best, Vi Lam, Tingting Liu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|March 15, 2014
Neisseria meningitidis as a cause of facial cellulitisBrent Ozaki, Adam Kittai, Suzanne Chang
Chemotherapy Research and Practice|October 24, 2012
Antiepidermal growth factor receptor monoclonal antibodies: applications in colorectal cancerEfat Azizi, Adam Kittai, Peter Kozuch
BMJ Case Reports|December 25, 2014
Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remissionAdam Kittai, Eun-Mi Yu, Imad Tabbara
Anticancer Research|September 27, 2015
Chronic Lymphocytic Leukemia: Current ConceptsEun-Mi Yu, Adam Kittai, Imad A Tabbara
Cancer Biology & Therapy|July 22, 2014
Ipilimumab: a potential immunologic agent in the treatment of metastatic castration-resistant prostate cancerAdam Kittai, Mariam Meshikhes, Jeanny B Aragon-Ching
Leukemia & Lymphoma|May 22, 2019
Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cellsScott Best, Tingting Liu, Nur Bruss, et al.
British Journal of Clinical Pharmacology|July 1, 2021
Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemiaVi Lam, Scott Best, Adam Kittai, et al.
Blood Advances|January 9, 2019
Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cellsScott Best, Taylor Hashiguchi, Adam Kittai, et al.
Cancer Management and Research|December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution ExperienceAndrew Schaefer, Ying Huang, Adam Kittai, et al.
Leukemia|March 24, 2020
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cellsScott Best, Vi Lam, Tingting Liu, et al.
Pageof 2